Companies & Industry »Company News»Company News Details
Company News Details

BSE   12 Dec 17 | 12:00 AM

2255.60 62.1 (2.83%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500124
Face Value: N.A.

NSE   12 Dec 17 | 12:00 AM

2256.35 63.45 (2.89%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: DRREDDY
Performance
1 Week : Rs 2,194.95 (2.76%)
1 Month : Rs 2,344.15 (-3.78%)
1 Year : Rs 3,164.90 (-28.73%)
change companytradenow
Back

Dr Reddy's seeks recovery this fiscal year

Press Trust of Inida / 31 Jul 17 | 06:08 AM

Dr Reddy's laboratory

After facing a “perfect storm" of adverse developments, Dr Reddy’s Laboratories expects a better performance this fiscal year, with cost reductions and new product launches.

Widgets Magazine


The Hyderabad-based firm saw consolidated revenue dip nine per cent in the last fiscal year to Rs 14,367.6 crore. It faced a multitude of issues, including US Food and Drug Administration (FDA) warning letters to three of its units.


It also faced intensive growth of competition in the US from other global generic players, delays in approval from the FDA and pricing pressure in various markets, including India.


The firm also witnesses economic crisis taking a toll on its once extremely profitable emerging market — Venezuela. Besides, its Active Pharmaceutical Ingredients, business was impacted due to lower offtake.


“The company went through a ‘perfect storm’ when several negative factors simultaneously came into play," Chairman K Satish Reddy and Co-Chairman G V Prasad said.

 

Widgets Magazine

Sensex

Company Price Gain (%)
Dr Reddy's Labs2,255.602.83
Adani Ports401.602.46
O N G C182.952.26
Lupin845.000.87
Infosys1,011.100.76

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine